Juliane Ray
General Manager, Commercial
Juliane Ray is the Global Head of Medtech Strategy at Clarivate. In this role, she connects people with intelligence, expertise and workflow tools to bring commercially successful treatments to patients faster and enable teams to make decisions with speed and confidence, from strategy through research and development and, ultimately, commercial execution.
Juliane has held several global leadership roles in the medical device and technology industries. She began her career in consulting at Deloitte and ZS Associates, where she collaborated with life sciences executives on commercial strategy. She spent more than 10 years leading marketing, strategy and operations teams at Cardiovascular Systems Inc (acquired by Abbott Vascular), American Medical Systems (acquired by Boson Scientific) and Landauer (acquired by Danaher) before joining Veeva as Vice President of Medtech Commercial Strategy in 2021 and joining Clarivate in 2024.
Juliane holds an MBA from the University of Virginia (Darden School of Business) and a BA in economics and international studies from Macalester College. She also serves as Board Chair at the Jungle, a nonprofit theater in her home city of Minneapolis, Minnesota.
Latest news
Clarivate Announces Sale of Life Sciences & Healthcare Segment for $600 Million
Transaction sharpens company’s focus on AI-driven transformative intelligence for its leading Academia & Government and Intellectual Property segments Enhances financial profile by improving revenue mix, expanding Adjusted EBITDA margin and…
